OKYO Pharma Ltd ADR (OKYO) — Net Asset Quality Index
OKYO Pharma Ltd ADR (OKYO) has a Net Asset Quality Index of 58.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $20.98 Million minus total liabilities of $8.64 Million yields net assets of $12.34 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does OKYO Pharma Ltd ADR carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
OKYO Pharma Ltd ADR Net Asset Quality Index Over Time (2008–2026)
This chart shows how OKYO Pharma Ltd ADR's Net Asset Quality Index has evolved across 19 annual periods from 2008 to 2026. As of June 2026, the index stands at 58.8%, representing net assets of $12.34 Million against total assets of $20.98 Million USD. For live market cap and overall valuation, see OKYO Pharma Ltd ADR (OKYO) market capitalisation.
Annual Net Asset Quality Index for OKYO Pharma Ltd ADR (2008–2026)
The table below presents the year-by-year Net Asset Quality Index for OKYO Pharma Ltd ADR from 2008 to 2026, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check OKYO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 58.8% | $12.34 Million | $20.98 Million | $8.64 Million | ▲ +209.7 pp |
| 2025 | -150.9% | $-5.55 Million | $3.68 Million | $9.23 Million | ▲ +230.6 pp |
| 2024 | -381.5% | $-5.88 Million | $1.54 Million | $7.42 Million | ▼ -342.0 pp |
| 2023 | -39.5% | $-2.05 Million | $5.20 Million | $7.26 Million | ▼ -108.0 pp |
| 2022 | 68.5% | $2.95 Million | $4.30 Million | $1.35 Million | ▼ -6.5 pp |
| 2021 | 75.0% | $5.32 Million | $7.09 Million | $1.77 Million | ▲ +98.4 pp |
| 2020 | -23.4% | $-139.80K | $597.40K | $737.20K | ▼ -67.2 pp |
| 2019 | 43.8% | $333.14K | $759.86K | $426.72K | ▼ -51.6 pp |
| 2018 | 95.5% | $1.92 Million | $2.01 Million | $91.06K | ▼ -3.6 pp |
| 2017 | 99.1% | $27.50 Million | $27.76 Million | $258.76K | ▼ -0.4 pp |
| 2016 | 99.4% | $32.00 Million | $32.18 Million | $181.34K | ▼ -0.1 pp |
| 2015 | 99.6% | $33.90 Million | $34.05 Million | $151.07K | ▲ +0.1 pp |
| 2014 | 99.5% | $46.96 Million | $47.21 Million | $247.95K | ▼ -0.1 pp |
| 2013 | 99.6% | $45.02 Million | $45.20 Million | $183.32K | ▲ +1.6 pp |
| 2012 | 98.0% | $41.36 Million | $42.20 Million | $832.89K | ▼ -1.5 pp |
| 2011 | 99.5% | $16.01 Million | $16.09 Million | $78.74K | ▼ -0.3 pp |
| 2010 | 99.9% | $54.05 Million | $54.13 Million | $79.87K | ▲ +0.1 pp |
| 2009 | 99.8% | $38.18 Million | $38.27 Million | $85.96K | ▲ +0.3 pp |
| 2008 | 99.5% | $27.46 Million | $27.60 Million | $144.86K | — |